-
Telaprevir (VX-950),
marketed under the
brand names Incivek and Incivo, is a
pharmaceutical drug for the
treatment of
hepatitis C co-developed by Vertex...
- 2014,
Vertex discontinued telaprevir. In May 2011, the Food and Drug
Administration (FDA) had
approved the drug
telaprevir (Incivek) as an oral treatment...
-
treated with interferon-α,
ribavirin and
protease inhibitors such as
telaprevir,
boceprevir or the
nucleotide analog polymerase inhibitor sofosbuvir....
-
Asunaprevir Boceprevir Grazoprevir Glecaprevir Paritaprevir Simeprevir Telaprevir 3-chymotrypsin-like
protease (including, but not
limited to,
severe acute...
- design.
Drugs developed include amprenavir, an HIV
protease inhibitor;
telaprevir, a
protease inhibitor for
treatment of
hepatitis C; and Kalydeco, for...
-
Taribavirin (Viramidine)
Hepatitis Syndromes in
which Ribavirin is
active Telaprevir Hepatitis C
Telbivudine (Tyzeka)
Hepatitis B
Tenofovir alafenamide Hepatitis...
- the
total synthesis of
commercially available pharmaceuticals such as
telaprevir (VX-950), an
antiviral sold by
Vertex Pharmaceuticals and
Johnson & Johnson...
-
Rembrandt toothpaste Rolaids RWJ-51204
Savlon Sinutab Splenda Sylvant Telaprevir Tipifarnib Buildings Johnson and
Johnson Plaza Related 2010
DePuy Hip...
-
following three classes: NS3 and NS4A
protease inhibitors,
including telaprevir, boceprevir, simeprevir, and
others NS5A inhibitors,
including ledipasvir...
- lopinavir, nefazodone, nelfinavir, posaconazole, ritonavir, saquinavir,
telaprevir, and
telithromycin (concomitant use not recommended); the
moderate CYP3A4...
